{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:55:04Z","timestamp":1794833704704,"version":"4.9.1"},"reference-count":224,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.survophthal.2025.01.017","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T09:50:43Z","timestamp":1739094643000},"page":"616-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0425-6033","authenticated-orcid":false,"given":"Manish","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi","family":"Mohankumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad A.","family":"Alkorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1200\/JGO.2015.000802","article-title":"Risk of selected cardiovascular toxicities in patients with cancer treated With MEK inhibitors: a comparative systematic review and meta-analysis","volume":"1","author":"Abdel-Rahman","year":"2015","journal-title":"J Glob Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/112067219700700317","article-title":"Central serous chorioretinopathy complicating systemic corticosteroid therapy","volume":"7","author":"Abu el-Asrar","year":"1997","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib3","article-title":"Sertraline-induced optic nerve dysfunction","volume":"15","author":"Abuallut","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.survophthal.2025.01.017_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/njvd.njvd_14_22","article-title":"Central serous chorioretinopathy following ingestion of sympathomimetics: a case report from Abuja, Nigeria","volume":"5","author":"Adeleye","year":"2022","journal-title":"Niger J Vitreoretina Dis"},{"key":"10.1016\/j.survophthal.2025.01.017_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.eye.6701905","article-title":"Central serous chorioretinopathy associated with testosterone therapy","volume":"20","author":"Ahad","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2025.01.017_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajo.2017.08.022","article-title":"Choroidal thinning associated with hydroxychloroquine retinopathy","volume":"183","author":"Ahn","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/fcp.12633","article-title":"Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: thinking about new indications","volume":"35","author":"Ala","year":"2021","journal-title":"Fundam Clin Pharm"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000333824","article-title":"Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?","volume":"227","author":"Aliferis","year":"2012","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3928\/1542-8877-20040301-16","article-title":"Central serous chorioretinopathy in a patient taking sildenafil citrate","volume":"35","author":"Allibhai","year":"2004","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2025.01.017_bib10","article-title":"Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use","volume":"26","author":"Alsberge","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1398-9995.2009.02123.x","article-title":"Allergic rhinitis: prevalence and possible risk factors in a Gulf Arab population","volume":"7","author":"Alsowaidi","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.survophthal.2025.01.017_bib12","article-title":"Central serous chorioretinopathy and selective serotonin reuptake inhibitors","author":"Altun","year":"2020","journal-title":"Res Sq"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib13","article-title":"Central serous chorioretinopathy in course of polycystic ovary syndrome - literature review","volume":"9","author":"Anna","year":"2022","journal-title":"JOJ Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/09273948.2011.619680","article-title":"Central serous chorioretinopathy associated with topical latanoprost therapy","volume":"19","author":"Artunay","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2025.01.017_bib15","first-page":"773","article-title":"Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report","volume":"14","author":"Asharari","year":"2021","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.survophthal.2025.01.017_bib16","article-title":"Bilateral serous detachment associated with latanoprost\/timolol fixed combination use: a report of one phakic case","volume":"2012","author":"AyhanTuzcu","year":"2012","journal-title":"Case Rep Ophthalmol Med"},{"key":"10.1016\/j.survophthal.2025.01.017_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.seizure.2022.03.024","article-title":"Molecular mechanisms of topiramate and its clinical value in epilepsy","volume":"98","author":"Bai","year":"2022","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/24741264221092908","article-title":"Erdafitinib-induced secondary maculopathy","volume":"6","author":"Becker","year":"2022","journal-title":"J Vitreoretin Dis"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/clpt.2008.3","article-title":"Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction","volume":"83","author":"Benowitz","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.survophthal.2025.01.017_bib20","first-page":"2805","article-title":"Topography of nitrergic intrinsic choroidal neurons (ICN) in the human eye","volume":"44","author":"Bergua","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib21","first-page":"Doc07","article-title":"Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses","volume":"9","author":"Beule","year":"2010","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/bjo.85.6.754-d","article-title":"Cyclical central serous chorioretinopathy associated with cystoid macular edema","volume":"85","author":"Birchall","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib23","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1002\/cne.23148","article-title":"Characterization of nitric oxide signaling pathways in the mouse retina","volume":"520","author":"Blom","year":"2012","journal-title":"J Comp Neurol"},{"issue":"24","key":"10.1016\/j.survophthal.2025.01.017_bib24","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.3390\/jcm10245960","article-title":"Uveitis and other ocular complications following COVID-19 vaccination","volume":"10","author":"Bolletta","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bjo.84.7.786","article-title":"A. Do sex and hormonal status influence choroidal circulation?","volume":"84","author":"Bonini","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2020.06.006","article-title":"Prospective impact of sildenafil on chronic central serous chorioretinopathy","author":"Breazzano","year":"2020","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2025.01.017_bib27","article-title":"Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use","volume":"15","author":"Brill","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000526052","article-title":"Sex hormones in males and females with active central serous chorioretinopathy","volume":"245","author":"Brinks","year":"2022","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3928\/23258160-20141118-16","article-title":"Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane","volume":"45","author":"Bussel","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"12","key":"10.1016\/j.survophthal.2025.01.017_bib30","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/IJG.0000000000002097","article-title":"The effect of latanoprost on choroidal vascularity index in glaucoma and ocular hypertension","volume":"31","author":"Cakir","year":"2022","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2025.01.017_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-198122040-00001","article-title":"Minoxidil: a review of its pharmacological properties and therapeutic use","volume":"22","author":"Campese","year":"1981","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/02713683.2016.1276196","article-title":"Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study","volume":"42","author":"Chatziralli","year":"2017","journal-title":"Curr Eye Res"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib33","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1007\/s10072-022-06176-8","article-title":"Steroid-induced central serous chorioretinopathy in neuromyelitis optica spectrum disorders: a case report","volume":"43","author":"Chen","year":"2022","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/2474126417739791","article-title":"Exogenous testosterone use and central serous chorioretinopathy","volume":"2","author":"Chen","year":"2018","journal-title":"J Vitreoretina Dis"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib35","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules22101551","article-title":"Current development status of MEK inhibitors","volume":"22","author":"Cheng","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib36","first-page":"S104","article-title":"Vertigo\/dizziness as a Drugs' adverse reaction","volume":"4","author":"Chimirri","year":"2013","journal-title":"J Pharm Pharm"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1120672120904670","article-title":"The significance of pigment epithelial detachment in central serous chorioretinopathy","volume":"31","author":"Chronopoulos","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/medicina57101063","article-title":"Changes in plasma VEGF and PEDF levels in patients with central serous chorioretinopathy","volume":"57","author":"Chrz\u0105szcz","year":"2021","journal-title":"Medicina"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jamaophthalmol.2013.47","article-title":"Management of fingolimod-associated macular edema","volume":"131","author":"Chui","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib40","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00417-018-3985-x","article-title":"The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels","volume":"256","author":"\u00c7ilo\u011flu","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/OPX.0000000000001833","article-title":"Case Report: Erdafitinib-induced Central Serous Chorioretinopathy","volume":"99","author":"Claiborne","year":"2022","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib42","article-title":"Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)","volume":"21","author":"Coleman","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221133163","article-title":"S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review","volume":"15","author":"Constantinescu","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ICB.0000000000000298","article-title":"Central serous chorioretinopathy in postmenopausal women receiving exogenous testosterone","volume":"11","author":"Conway","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib45","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1073\/pnas.0402044101","article-title":"Potent block of Cx36 and Cx50 gap junction channels by mefloquine","volume":"101","author":"Cruikshank","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40942-020-00241-0","article-title":"Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review","author":"da Cruz","year":"2020","journal-title":"Int J Retin Vitr"},{"issue":"11","key":"10.1016\/j.survophthal.2025.01.017_bib47","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s10792-020-01501-6","article-title":"Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series","volume":"40","author":"Da\u011f","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.exer.2008.01.021","article-title":"Focus on molecules: connexin 43 \u2013 mind the gap","volume":"87","author":"Danesh-Meyer","year":"2008","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.survophthal.2025.01.017_bib49","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s00417-020-04907-1","article-title":"Choroidal evaluation in patients under alpha-lytic therapy","volume":"258","author":"De Bernardo","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib50","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jfo.2021.11.003","article-title":"Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: a case report","volume":"45","author":"Delbarre","year":"2022","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0028-3886.42005","article-title":"Retinal detachment presumably associated with topiramate","volume":"56","author":"Dey","year":"2008","journal-title":"Neurol India"},{"key":"10.1016\/j.survophthal.2025.01.017_bib52","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2147\/OPTH.S219347","article-title":"Choroidal thickness changes in systemic lupus erythematosus patients","volume":"13","author":"Dias-Santos","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib53","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5606\/tftrd.2021.5433","article-title":"\u0130. Pregabalin as a probable cause of central serous chorioretinopathy: two case reports","volume":"67","author":"Do\u011fan","year":"2021","journal-title":"Turk J Phys Med Rehabil"},{"key":"10.1016\/j.survophthal.2025.01.017_bib54","first-page":"Doc13","article-title":"Central serous chorioretinopathy following oral quetiapine","volume":"13","author":"Durmaz Engin","year":"2023","journal-title":"GMS Ophthalmol Cases"},{"key":"10.1016\/j.survophthal.2025.01.017_bib55","article-title":"Caffeine's vascular mechanisms of action","volume":"2010","author":"Echeverri","year":"2010","journal-title":"Int J Vasc Med"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","article-title":"Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients","volume":"103","author":"Ersoz","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/1039856214556327","article-title":"Bilateral maculopathy associated with sertraline","volume":"22","author":"Ewe","year":"2014","journal-title":"Austral Psychiatry"},{"key":"10.1016\/j.survophthal.2025.01.017_bib58","article-title":"Is tobacco consumption a risk factor for central serous chorioretinopathy? A systematic review and meta-analysis","author":"Fakhril-Din","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2002.tb04181.x","article-title":"Action of MDMA (Ecstasy) and its metabolites on arginine vasopressin release","volume":"965","author":"Fallon","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib60","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1167\/iovs.10-5964","article-title":"Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa","volume":"52","author":"Falsini","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2025.01.017_bib61","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/13543780903066764","article-title":"Investigational vasopressin receptor modulators in the pipeline","volume":"18","author":"Favory","year":"2009","journal-title":"Expert Opin Invest Drugs"},{"issue":"9","key":"10.1016\/j.survophthal.2025.01.017_bib62","first-page":"694","article-title":"Corticotroph cell hyperplasia as a rare cause of ACTH-dependent cushing syndrome","volume":"69","author":"Ferri","year":"2022","journal-title":"Endocrinol Diabetes Nutr (Engl Ed"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib63","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1159\/000524992","article-title":"Chronic central serous chorioretinopathy with pigment epithelium detachment treated with sildenafil: a case report","volume":"13","author":"Finzi","year":"2022","journal-title":"Case Rep Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1878-5085-4-14","article-title":"The primary vascular dysregulation syndrome: implications for eye diseases","volume":"4","author":"Flammer","year":"2013","journal-title":"EPMA J"},{"key":"10.1016\/j.survophthal.2025.01.017_bib65","first-page":"592","article-title":"Species differences in choroid vasodilative innervation: evidence for specific intrinsic nitrergic and VIP-positive neurons in the human eye","volume":"35","author":"Flugel","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000310728","article-title":"Presence of a contractile cell network in the human choroid","volume":"210","author":"Flugel-Koch","year":"1996","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib67","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00006982-200408000-00023","article-title":"Central serous chorioretinopathy associated with anthrax vaccination","volume":"24","author":"Foster","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.01.017_bib68","article-title":"Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine","volume":"23","author":"Fowler","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib69","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40261-019-00804-6","article-title":"Severe exacerbation of multiple sclerosis following withdrawal of fingolimod","volume":"39","author":"Fragoso","year":"2019","journal-title":"Clin Drug Invest"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/IAE.0b013e31815ec2c8","article-title":"Central serous chorioretinopathy associated with sildenafil","volume":"28","author":"Fraunfelder","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.01.017_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mam.2016.11.011","article-title":"Low, but not high, dose caffeine is a readily available probe for adenosine actions","volume":"55","author":"Fredholm","year":"2017","journal-title":"Mol Asp Med"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/IAE.0b013e3181b7740f","article-title":"Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study","volume":"30","author":"French","year":"2010","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ceo.14201","article-title":"Central serous chorioretinopathy: A review","volume":"51","author":"Fung","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/ICB.0b013e3182437db8","article-title":"Central serous chorioretinopathy associated with the use of spironolactone, aldosterone receptor antagonist","volume":"6","author":"Gabrielian","year":"2012","journal-title":"Retin cases Brief Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.oftal.2020.11.018","article-title":"Bilateral neurosensory retinal detachment secondary to tadalafil treatment","volume":"97","author":"Gargallo-Benedicto","year":"2022","journal-title":"Arch Soc Esp Oftalmol (Engl Ed"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib76","first-page":"446","article-title":"The relation of the serum aldosterone level and central serous chorioretinopathy - a pilot study","volume":"21","author":"Gong","year":"2017","journal-title":"Eur Rev Med Pharm Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib77","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/eye.2011.250","article-title":"Central serous chorioretinopathy following oral tadalafil","volume":"26","author":"Gordon-Bennett","year":"2012","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib78","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1167\/iovs.18-26381","article-title":"New insights on choroidal vascularity: a comprehensive topographic approach","volume":"60","author":"Goud","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0161-6420(91)32216-4","article-title":"Beta-adrenergic responsiveness of choroidal vasculature","volume":"98","author":"Grajewski","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bjo.2006.098277","article-title":"The potential role of testosterone in central serous chorioretinopathy","volume":"91","author":"Grieshaber","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnmol.2016.00090","article-title":"KIR4.1: K+ Channel illusion or reality in the autoimmune pathogenesis of multiple sclerosis","volume":"9","author":"Gu","year":"2016","journal-title":"Front Mol Neurosci"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib82","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/j.jfo.2020.03.007","article-title":"Chorior\u00e9tinopathie s\u00e9reuse centrale et minoxidil 2 [Central serous chorioretinopathy associated with minoxidil 2]","volume":"43","author":"Guillon-Rolf","year":"2020","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib83","article-title":"Ocular hemodynamics in epileptic children treated with antiepileptic drugs","author":"Gultutan","year":"2023","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib84","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0161-6420(97)30082-7","article-title":"Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids","volume":"104","author":"Haimovici","year":"1997","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/IAE.0000000000003638","article-title":"Choroidal vascularity index in hydroxychloroquine toxic retinopathy: a quantitative comparative analysis using enhanced depth imaging in spectral domain optical coherence tomography","volume":"43","author":"Halouani","year":"2023","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib87","first-page":"130","article-title":"Ocular Toxicities of MEK inhibitors in patients with cancer: a systematic review and meta-analysis","volume":"37","author":"Han","year":"2023","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jfo.2022.01.006","article-title":"Central serous chorioretinopathy following the BNT162b2 mRNA vaccine","volume":"45","author":"Hanhart","year":"2022","journal-title":"J Fr Ophtalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib89","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41433-023-02747-x","article-title":"Effects of hydroxychloroquine therapy on choroidal volume and choroidal vascularity index","volume":"38","author":"Hasan","year":"2024","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib90","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00006982-200110000-00030","article-title":"Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or \"ecstasy\"","volume":"21","author":"Hassan","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.01.017_bib91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2006.05.009","article-title":"The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux","volume":"29","author":"Hayeshi","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237243","article-title":"Non-central serous chorioretinopathy in a patient with systemic lupus erythematosus and hydroxychloroquine retinopathy","volume":"14","author":"Hipolito-Fernandes","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.885489","article-title":"Biologically active compounds present in tobacco smoke: potential interactions between smoking and mental health","volume":"16","author":"Hong","year":"2022","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib94","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/15569527.2023.2235429","article-title":"Evaluation of choroidal thickness and choroidal vascular index in patients using combined oral contraceptive pills","volume":"42","author":"Icoz","year":"2023","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib95","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41433-020-0995-9","article-title":"Effects of different mydriatics on the choroidal vascularity in healthy subjects","volume":"35","author":"Iovino","year":"2021","journal-title":"Eye (Lond)"},{"issue":"43","key":"10.1016\/j.survophthal.2025.01.017_bib96","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005102","article-title":"What ocular and systemic variables affect choroidal circulation in healthy eyes","volume":"95","author":"Iwase","year":"2016","journal-title":"Med (Baltim)"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib97","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/ijo.IJO_929_18","article-title":"Quetiapine associated Central Serous Chorioretinopathy: Implicit role of serotonin and dopamine pathways","volume":"67","author":"Jain","year":"2019","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.01.017_bib98","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: incidence, detection, and management","volume":"78","author":"Jain","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib99","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/2211-5056.361975","article-title":"The associations between central serous chorioretinopathy and muscle relaxants: a case-control study","volume":"12","author":"Jain","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib100","article-title":"Clinical profile and risk factors of central serous chorioretinopathy in Al-Ain, United Arab Emirates","volume":"3","author":"Jain","year":"2022","journal-title":"N Emir Med J"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib101","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/2211-5056.362601","article-title":"Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification","volume":"12","author":"Jain","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13256-016-1091-4","article-title":"Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report","volume":"10","author":"Jain","year":"2016","journal-title":"J Med Case Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib103","first-page":"250","article-title":"Maculopathy a corticosteroid side-effect","volume":"14","author":"Jain","year":"1966","journal-title":"J All India Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib104","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40123-021-00340-7","article-title":"Presumed sertraline-associated maculopathy: a case series","volume":"10","author":"Javidi","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2025.01.017_bib105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/a-1403-3068","article-title":"Drug-induced pseudo-central serous chorioretinopathy in carcinoma patients","volume":"238","author":"Jung","year":"2021","journal-title":"Klin Mon\u00e4tter F\u00fcR Augenheilkd"},{"key":"10.1016\/j.survophthal.2025.01.017_bib106","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-021-01961-4","article-title":"Comparison of effects of tamsulosin and silodosin on subfoveal choroidal thickness and pupil size diameters in patients with prostatic hyperplasia","author":"Kanar","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjophthalmol-2015-306969","article-title":"The effect of consumption of ethanol on subfoveal choroidal thickness in acute phase","volume":"100","author":"Kang","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib108","doi-asserted-by":"crossref","first-page":"NP56","DOI":"10.1177\/1120672121999632","article-title":"Fingolimod-associated macular edema: a case report of late onset","volume":"32","author":"Karakosta","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.18502\/jovr.v18i4.14553","article-title":"Central serous chorioretinopathy risk factors in an iranian cohort: a case-control study","volume":"18","author":"Karimi","year":"2023","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2025.01.017_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2025.01.017_bib111","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1167\/iovs.09-4847","article-title":"Immunolocalization of gap junction protein connexin43 (GJA1) in the human retina and optic nerve","volume":"51","author":"Kerr","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib112","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WNO.0000000000000592","article-title":"Central Serous Chorioretinopathy Associated with Fingolimod Treatment","volume":"38","author":"Khimani","year":"2018","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib113","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/exer.1999.0717","article-title":"Modulation of choroidal autoregulation in the rabbit","volume":"69","author":"Kiel","year":"1999","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2025.01.017_bib114","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/OPX.0b013e318264f657","article-title":"Influence of mydriatics on choroidal thickness measurement using enhanced depth imaging-OCT","volume":"89","author":"Kim","year":"2012","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040558","article-title":"Central serous chorioretinopathy and blood serotonin concentrations","volume":"10","author":"Kimura","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2025.01.017_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206646","article-title":"Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy","volume":"13","author":"Kishi","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib117","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000485912","article-title":"Central serous chorioretinopathy associated with desmopressin nasal spray: causality or unfortunate association","volume":"9","author":"Kisma","year":"2018","journal-title":"Case Rep Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib118","first-page":"605","article-title":"Effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus evaluated with a laser speckle microcirculation analyser","volume":"101","author":"Kojima","year":"1997","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.survophthal.2025.01.017_bib119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajoc.2016.05.004","article-title":"The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors","volume":"3","author":"Koulisis","year":"2016","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.preteyeres.2012.04.004","article-title":"Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease","volume":"31","author":"Kur","year":"2012","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib121","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.01.017_bib122","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.18240\/ijo.2020.09.15","article-title":"Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis","volume":"13","author":"Lee","year":"2020","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib123","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00041327-199912000-00004","article-title":"Toxic optic neuropathy after concomitant use of melatonin, zoloft, and a high-protein diet","volume":"19","author":"Lehman","year":"1999","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.01.017_bib125","first-page":"885","article-title":"Finasteride-Associated Central Serious Chorioretinopathy","volume":"31","author":"Lombardo","year":"2008","journal-title":"Drug-Saf"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib126","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.psy.0000181270.20036.06","article-title":"Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels","volume":"67","author":"Lovallo","year":"2005","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib127","article-title":"Prevalence and triggers of allergic rhinitis in the United Arab Emirates","volume":"7","author":"Mahboub","year":"2014","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.oret.2017.02.009","article-title":"Physiologic and Psychologic Risk Factors in Central Serous Chorioretinopathy","volume":"1","author":"Mansour","year":"2017","journal-title":"Ophthalmol Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/ICB.0000000000000115","article-title":"Bull'S eye maculopathy in a patient taking sertraline","volume":"9","author":"Mason","year":"2015","journal-title":"Retin Cases Brief Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib130","doi-asserted-by":"crossref","first-page":"NP21","DOI":"10.1177\/1120672118797286","article-title":"Acquired myopia followed by acquired hyperopia due to serous neurosensory retinal detachment following topiramate intake","volume":"29","author":"Mazumdar","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/j.2040-4603.2015.tb00603.x","article-title":"Autonomic control of the eye","volume":"5","author":"McDougal","year":"2015","journal-title":"Compr Physiol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib132","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2165\/11207410-000000000-00000","article-title":"Ulipristal acetate: a review of its use in emergency contraception","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib133","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jfo.2022.02.001","article-title":"Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine","volume":"45","author":"Mechleb","year":"2022","journal-title":"J Fr Ophtalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.01.017_bib134","article-title":"The ophthalmic side effects of topiramate: a review","volume":"14","author":"Mechrgui","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.survophthal.2025.01.017_bib135","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1523\/JNEUROSCI.07-12-03827.1987","article-title":"Cholinergic innervation of the smooth muscle cells in the choroid coat of the chick eye and its development","volume":"7","author":"Meriney","year":"1987","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib136","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0002-9394(03)00076-X","article-title":"Central serous chorioretinopathy associated with administration of sympathomimetic agents","volume":"136","author":"Michael","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/OPTO.S210877","article-title":"Central serous chorioretinopathy following ingestion of sildenafil citrate","volume":"11","author":"Mohammadpour","year":"2019","journal-title":"Clin Optom (Auckl)"},{"key":"10.1016\/j.survophthal.2025.01.017_bib138","first-page":"236","article-title":"Acute central serous chorioretinopathy following topical minoxidil use for androgenic alopecia - A case report. TNOA J Ophthalmic","volume":"61","author":"Mohankumar","year":"2023","journal-title":"Sci Res"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib139","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/eye.2016.53","article-title":"Finasteride is effective for the treatment of central serous chorioretinopathy","volume":"30","author":"Moisseiev","year":"2016","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.oftal.2017.12.012","article-title":"Acute bilateral serous central chorioretinopathy after emergency contraceptive therapy with ulipristal acetate","volume":"93","author":"Molina Mart\u00edn","year":"2018","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib141","article-title":"Central serous chorioretinopathy induced by drugs metabolized by cytochrome P450 3A4","volume":"71","author":"Morawski","year":"2020","journal-title":"J Physiol Pharm"},{"key":"10.1016\/j.survophthal.2025.01.017_bib142","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1444-0938.2012.00771.x","article-title":"Macular edema due to letrozole: a first case report","volume":"95","author":"Moschos","year":"2012","journal-title":"Clin Exp Optom"},{"issue":"12","key":"10.1016\/j.survophthal.2025.01.017_bib143","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.oftal.2019.07.014","article-title":"Macular neurosensory retinal detachment associated with topiramate use","volume":"94","author":"Mu\u00f1oz Morales","year":"2019","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib144","first-page":"727","article-title":"A case of central serous chorioretinopathy after sildenafl (Viagra)","volume":"42","author":"Murata","year":"2000","journal-title":"Kyushu Ganka Gakkai"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2017.06.008","article-title":"Central serous chorioretinopathy and glucocorticoids: an update on evidence for association","volume":"63","author":"Nicholson","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib146","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2025.01.017_bib147","article-title":"Instances of ocular findings in transgender patients undergoing hormonal therapy","volume":"32","author":"Nieves-R\u00edos","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib148","article-title":"Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment","volume":"27","author":"Noda","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib149","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/IAE.0000000000000198","article-title":"Central serous chorioretinopathy in patients receiving exogenous testosterone therapy","volume":"34","author":"Nudleman","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.01.017_bib150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fendo.2018.00066","article-title":"Gonadal hormones and retinal disorders: a review","volume":"9","author":"Nuzzi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib151","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/112067210801800627","article-title":"Serous detachment of macula in cystoid macular edema associated with latanoprost","volume":"18","author":"Ozdemir","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib152","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10792-007-9137-7","article-title":"Serous retinal detachment in the macula related to latanoprost use","volume":"28","author":"Ozkan","year":"2008","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib153","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3341\/kjo.2018.0067","article-title":"Pediatric case with acute bilateral serous macular detachment","volume":"33","author":"Ozturkmen","year":"2019","journal-title":"Korean J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib154","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.oftal.2013.04.007","article-title":"Coriorretinopat\u00eda serosa central de etiolog\u00eda inusual: a prop\u00f3sito de dos casos [Central serous chorioretinopathy of unusual etiology: A report of 2 cases]","volume":"89","author":"Palacios","year":"2014","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib155","article-title":"Serous macular detachments associated with topical travoprost","volume":"15","author":"Patheja","year":"2022","journal-title":"BMJ Case Rep CP"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib156","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/09273948.2021.1887279","article-title":"Ocular adverse events following yellow fever vaccination: a case series","volume":"30","author":"Pereima","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib157","article-title":"Cocaine and cardiotoxicity: a literature review","volume":"13","author":"Pergolizzi","year":"2021","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib158","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1167\/iovs.18-23995","article-title":"Choroidal vascular reactivity in central serous chorioretinopathy","volume":"59","author":"Piccolino","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.survophthal.2025.01.017_bib159","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi","volume":"139","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib160","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ICB.0b013e31818ad3ce","article-title":"Central serous chorioretinopathy associated with the use of ephedra","volume":"3","author":"Pierce","year":"2009","journal-title":"Retin Cases Brief Rep"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib161","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00010.2019","article-title":"Connexins: key players in the control of vascular plasticity and function","volume":"100","author":"Pohl","year":"2020","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.survophthal.2025.01.017_bib162","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243207","article-title":"Fingolimod-associated central serous chorioretinopathy in a young girl","volume":"14","author":"Pratima","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib163","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0161-6420(96)30730-6","article-title":"Central serous chorioretinopathy in women","volume":"103","author":"Quillen","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2025.01.017_bib164","doi-asserted-by":"crossref","unstructured":"Rado J.P., Juhos E.Rado J.P., Juhos E.: Effect of 1-deamino-5-D-arginine vasopressin (DDAVP) on plasma cortisol (hydrocortisone). J Clin Pharmacol 1976;16:333\u2013337..","DOI":"10.1002\/j.1552-4604.1976.tb01529.x"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib165","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/08820538.2022.2082255","article-title":"Acute unilateral central serous chorioretinopathy after immunization with pfizer-BioNTech COVID-19 vaccine: a case report and literature review","volume":"37","author":"Rama Raj","year":"2022","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib166","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10799891003786234","article-title":"Alopecia and ocular alterations: a role for Minoxidil?","volume":"30","author":"Rastmanesh","year":"2010","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib167","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICB.0b013e3182235561","article-title":"Chronic central serous chorioretinopathy responsive to rifampin","volume":"6","author":"Ravage","year":"2012","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib168","first-page":"2645","article-title":"Age-related ocular blood flow changes","volume":"37","author":"Ravalico","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib169","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.preteyeres.2017.12.001","article-title":"Neural control of choroidal blood flow","volume":"64","author":"Reiner","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib170","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.03-0997","article-title":"Dopaminergic vasodilation in the choroidal circulation by d1\/d5 receptor activation","volume":"45","author":"Reitsamer","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib171","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pharmthera.2008.10.006","article-title":"Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease","volume":"121","author":"Riksen","year":"2009","journal-title":"Pharm Ther"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib172","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bjo.84.1.76","article-title":"Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues","volume":"84","author":"Rocha","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib173","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bjo.33.6.358","article-title":"The significance of ocular complications following vaccination","volume":"33","author":"Rosen","year":"1949","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib174","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajoc.2017.05.005","article-title":"Topiramate-induced macular neurosensory retinal detachment","volume":"7","author":"Rosenberg","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2025.01.017_bib175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib176","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biom12030389","article-title":"Desmopressin stimulates nitric oxide production in human lung microvascular endothelial cells","volume":"12","author":"Rotoli","year":"2022","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib177","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cxo.12141","article-title":"Central serous chorioretinopathy following oral tadalafil intake","volume":"97","author":"Roy","year":"2014","journal-title":"Clin Exp Optom"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib178","doi-asserted-by":"crossref","first-page":"652","DOI":"10.5935\/0004-2749.2022-0243","article-title":"Topiramate-induced bilateral central serous chorioretinopathy","volume":"85","author":"\u015eahin","year":"2022","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2025.01.017_bib179","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00417-017-3791-x","article-title":"Relationship between choroidal blood flow velocity and choroidal thickness in patients with regression of acute central serous chorioretinopathy","volume":"256","author":"Saito","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthal"},{"key":"10.1016\/j.survophthal.2025.01.017_bib180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2012-302349","article-title":"Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy","volume":"97","author":"Saito","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib181","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.oret.2016.09.003","article-title":"Reduced blood serotonin levels in chronic central serous chorioretinopathy","volume":"1","author":"Sakai","year":"2017","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2025.01.017_bib182","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.exer.2014.10.003","article-title":"The effect of topical adrenergic and anticholinergic agents on the choroidal thickness of young healthy adults","volume":"128","author":"Sander","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2025.01.017_bib183","article-title":"Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study","volume":"27","author":"Sanjay","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib184","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00347-002-0654-5","article-title":"Increased myopia and metaporphosia in a 59-year-old patient","volume":"100","author":"Sauer","year":"2003","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/15569527.2011.613427","article-title":"Central chorioretinopathy associated with topical use of minoxidil 2% for treatment of baldness","volume":"31","author":"Scarinci","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib186","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.survophthal.2007.08.008","article-title":"How can blood flow be measured?","volume":"52","author":"Schmetterer","year":"2007","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib187","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1034\/j.1600-0420.2001.079004428.x","article-title":"Presumed sertraline maculopathy","volume":"79","author":"Sener","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2025.01.017_bib188","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1097\/IAE.0000000000003166","article-title":"Quantification of vessels of haller's layer based on en-face optical coherence tomography images","volume":"41","author":"Shiihara","year":"2021","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib189","first-page":"179","article-title":"Letrozole induced central serous chorioretinopathy: a rare case report","volume":"4","author":"Shivaranjani","year":"2018","journal-title":"Ophthalmol Allied Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib190","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4103\/ijo.IJO_1629_22","article-title":"Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford\/AstraZeneca AZD1222 (Covishield) vaccine","volume":"71","author":"Sindhu","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"16","key":"10.1016\/j.survophthal.2025.01.017_bib191","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1038\/s41433-023-02509-9","article-title":"Randomized controlled trials in central serous chorioretinopathy: A review","volume":"37","author":"Singh","year":"2023","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib192","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40942-023-00480-x","article-title":"Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study","volume":"9","author":"Sorour","year":"2023","journal-title":"Int J Retin Vitr"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib193","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40123-023-00658-4","article-title":"Risk of central serous chorioretinopathy in male androgen abusers","volume":"12","author":"Subhi","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib194","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1167\/iovs.03-0733","article-title":"Nicotine increases size and severity of experimental choroidal neovascularization","volume":"45","author":"Su\u00f1er","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.01.017_bib195","first-page":"699","article-title":"Vasodilatory mechanisms of unoprostone isopropyl in isolated porcine retinal arterioles","volume":"21","author":"Tanano","year":"2015","journal-title":"Mol Vis"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib196","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions","volume":"113","author":"Tanoue","year":"2004","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib197","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"issue":"8","key":"10.1016\/j.survophthal.2025.01.017_bib198","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1167\/iovs.05-1246","article-title":"Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study","volume":"47","author":"Tewari","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2025.01.017_bib199","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/IAE.0000000000000159","article-title":"Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan","volume":"34","author":"Tsai","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.01.017_bib200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/bdd.343","article-title":"Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A","volume":"24","author":"Tsujikawa","year":"2003","journal-title":"Biopharm Drug Dispos"},{"issue":"3","key":"10.1016\/j.survophthal.2025.01.017_bib201","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00417-012-2075-8","article-title":"Serum cortisol and testosterone levels in chronic central serous chorioretinopathy","volume":"251","author":"Tufan","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10792-012-9646-x","article-title":"Central serous chorioretinopathy due to tadalafil use","volume":"33","author":"T\u00fcrkc\u00fc","year":"2013","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(98)00230-2","article-title":"The role of corticosteroids in the regulation of vascular tone","volume":"41","author":"Ullian","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.survophthal.2025.01.017_bib204","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-87-4-398","article-title":"GH. Pathophysiology of spironolactone-induced gynecomastia","volume":"87","author":"Underwood","year":"1977","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib205","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1530\/EJE-18-0007","article-title":"Diagnosis of endocrine disease: The role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome","volume":"178","author":"Vassiliadi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12886-020-01499-6","article-title":"Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report","volume":"20","author":"Venkatesh","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.01.017_bib207","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.oret.2021.09.008","article-title":"Alphabet soup: clinical pearls for the retina specialist-ocular toxicity of advanced antineoplastic agents in systemic cancer care","volume":"5","author":"Villegas","year":"2021","journal-title":"Ophthalmol Retin"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib208","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/IAE.0000000000000043","article-title":"Choroidal thickness changes after a single administration of coffee in healthy subjects","volume":"34","author":"Vural","year":"2014","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib209","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bjo.68.5.329","article-title":"Central serous chorioretinopathy complicating systemic corticosteroid treatment","volume":"68","author":"Wakakura","year":"1984","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3129\/can.j.ophthalmol.06-093","article-title":"Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis","volume":"42","author":"Walker","year":"2007","journal-title":"Can J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.01.017_bib211","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1167\/iovs.17-21825","article-title":"Peripheral vascular endothelial dysfunction in central serous chorioretinopathy","volume":"58","author":"Wang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1470320314549791","article-title":"Expression of classical components of the renin-angiotensin system in the human eye","volume":"16","author":"White","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib213","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bjo.54.6.405","article-title":"Macular lesions during systemic therapy with depot tetracosactrin","volume":"54","author":"Williamson","year":"1970","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib214","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3928\/23258160-20150610-16","article-title":"Polycystic ovary syndrome and central serous chorioretinopathy","volume":"46","author":"Witmer","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2025.01.017_bib215","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/1120672120908719","article-title":"En-face choroidal vascularity in central serous chorioretinopathy","volume":"31","author":"Wong","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.01.017_bib216","first-page":"633","article-title":"Ephedra\/ephedrine: cardiovascular and CNS effects","volume":"166","author":"Wooltorton","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.survophthal.2025.01.017_bib217","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.2147\/DDDT.S381957","article-title":"The temporal topography of central serous chorioretinopathy in the chinchilla rabbits induced by intravenous injection of adrenaline: an in vivo study","volume":"16","author":"Yan","year":"2022","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.survophthal.2025.01.017_bib218","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1111\/bcp.15237","article-title":"The effect of systemic and topical ophthalmic medications on choroidal thickness: A review","volume":"88","author":"Yeung","year":"2022","journal-title":"Br J Clin Pharm"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib219","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12802","article-title":"Melatonin prevents experimental central serous chorioretinopathy in rats","volume":"73","author":"Yu","year":"2022","journal-title":"J Pineal Res"},{"key":"10.1016\/j.survophthal.2025.01.017_bib220","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/981274","article-title":"An evaluation of effects of different mydriatics on choroidal thickness by examining anterior chamber parameters: the scheimpflug imaging and enhanced depth imaging-OCT study","volume":"2015","author":"Yuvac\u0131 \u0130","year":"2015","journal-title":"J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.01.017_bib221","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","article-title":"Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis","volume":"120","author":"Zarbin","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2025.01.017_bib222","article-title":"Effect of mydriasis on macular and peripapillary metrics in swept-source optical coherence tomography angiography","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.survophthal.2025.01.017_bib223","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2147\/TCRM.S370133","article-title":"The association between circulating sex hormones and central serous chorioretinopathy: a case-control study","volume":"18","author":"Zhao","year":"2022","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.survophthal.2025.01.017_bib224","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/WNO.0000000000000937","article-title":"Choriocapillaris integrity in relapsed central serous chorioretinopathy in a patient treated with fingolimod for multiple sclerosis: new insights from optical coherence tomography angiography","volume":"41","author":"Ziccardi","year":"2021","journal-title":"J Neuro-Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T09:28:18Z","timestamp":1747474098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":224,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0039625725000207"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.01.017","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}